ROS-mediated activation of AKT induces apoptosis via pVHL in prostate cancer cells

被引:60
作者
Chetram, Mahandranauth A. [1 ]
Bethea, Danaya A. [1 ]
Odero-Marah, Valerie A. [1 ]
Don-Salu-Hewage, Ayesha S. [1 ]
Jones, Kia J. [1 ]
Hinton, Cimona V. [1 ]
机构
[1] Clark Atlanta Univ, Ctr Canc Res & Therapeut Dev, Atlanta, GA 30314 USA
基金
美国国家科学基金会; 美国国家卫生研究院;
关键词
ROS; p-AKT; HIF1; alpha; pVHL; Apoptosis; Prostate cancer; HIPPEL-LINDAU PROTEIN; TUMOR-SUPPRESSOR; KINASE B; PHOSPHORYLATION; PTEN; SURVIVAL; PATHWAY; INACTIVATION;
D O I
10.1007/s11010-012-1549-7
中图分类号
Q2 [细胞生物学];
学科分类号
071013 [干细胞生物学];
摘要
Reactive oxygen species (ROS) play a central role in oxidative stress, which leads to the onset of diseases, such as cancer. Furthermore, ROS contributes to the delicate balance between tumor cell survival and death. However, the mechanisms by which tumor cells decide to elicit survival or death signals during oxidative stress are not completely understood. We have previously reported that ROS enhanced tumorigenic functions in prostate cancer cells, such as transendothelial migration and invasion, which depended on CXCR4 and AKT signaling. Here, we report a novel mechanism by which ROS facilitated cell death through activation of AKT. We initially observed that ROS enhanced the expression of phosphorylated AKT (p-AKT) in 22Rv1 human prostate cancer cells. The tumor suppressor PTEN, a negative regulator of AKT signaling, was rendered catalytically inactive through oxidation by ROS, although the expression levels remained consistent. Despite these events, cells still underwent apoptosis. Further investigation into apoptosis revealed that expression of the tumor suppressor pVHL increased, and contains a target site for p-AKT phosphorylation. pVHL and p-AKT associated in vitro, and knockdown of pVHL rescued HIF1 alpha expression and the cells from apoptosis. Collectively, our study suggests that in the context of oxidative stress, p-AKT facilitated apoptosis by inducing pVHL function.
引用
收藏
页码:63 / 71
页数:9
相关论文
共 35 条
[1]
Mechanism of activation of protein kinase B by insulin and IGF-1 [J].
Alessi, DR ;
Andjelkovic, M ;
Caudwell, B ;
Cron, P ;
Morrice, N ;
Cohen, P ;
Hemmings, BA .
EMBO JOURNAL, 1996, 15 (23) :6541-6551
[2]
Phosphorylation of HDM2 by Akt [J].
Ashcroft, M ;
Ludwig, RL ;
Woods, DB ;
Copeland, TD ;
Weber, HO ;
MacRae, EJ ;
Vousden, KH .
ONCOGENE, 2002, 21 (13) :1955-1962
[3]
Mitochondria, oxidants, and aging [J].
Balaban, RS ;
Nemoto, S ;
Finkel, T .
CELL, 2005, 120 (04) :483-495
[4]
Apoptotic volume decrease and the incredible shrinking cell [J].
Bortner, CD ;
Cidlowski, JA .
CELL DEATH AND DIFFERENTIATION, 2002, 9 (12) :1307-1310
[5]
New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase AKT pathway [J].
Cantley, LC ;
Neel, BG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (08) :4240-4245
[6]
ROS enhances CXCR4-mediated functions through inactivation of PTEN in prostate cancer cells [J].
Chetram, Mahandranauth A. ;
Don-Salu-Hewage, Ayesha S. ;
Hinton, Cimona V. .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2011, 410 (02) :195-200
[7]
Loss of PTEN Permits CXCR4-Mediated Tumorigenesis through ERK1/2 in Prostate Cancer Cells [J].
Chetram, Mahandranauth A. ;
Odero-Marah, Valerie ;
Hinton, Cimona V. .
MOLECULAR CANCER RESEARCH, 2011, 9 (01) :90-102
[8]
Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery [J].
Datta, SR ;
Dudek, H ;
Tao, X ;
Masters, S ;
Fu, HA ;
Gotoh, Y ;
Greenberg, ME .
CELL, 1997, 91 (02) :231-241
[9]
A novel AKT3 mutation in melanoma tumours and cell lines [J].
Davies, M. A. ;
Stemke-Hale, K. ;
Tellez, C. ;
Calderone, T. L. ;
Deng, W. ;
Prieto, V. G. ;
Lazar, A. J. F. ;
Gershenwald, J. E. ;
Mills, G. B. .
BRITISH JOURNAL OF CANCER, 2008, 99 (08) :1265-1268
[10]
Gunn Richard M, 2008, J Chem Biol, V1, P49, DOI 10.1007/s12154-008-0008-0